XTL Biopharmaceuticals Ltd. (XTLB)
1.98
-0.01
(-0.50%)
USD |
NASDAQ |
Oct 09, 16:00
1.98
0.00 (0.00%)
After-Hours: 20:00
XTL Biopharmaceuticals Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 0.8027 |
| October 08, 2026 | 0.8068 |
| October 07, 2026 | 0.8027 |
| October 06, 2026 | 0.819 |
| October 05, 2026 | 0.8838 |
| October 02, 2026 | 0.8757 |
| October 01, 2026 | 0.8636 |
| September 30, 2026 | 0.9325 |
| September 29, 2026 | 0.896 |
| September 28, 2026 | 0.9041 |
| September 25, 2026 | 0.892 |
| September 24, 2026 | 0.9771 |
| September 23, 2026 | 0.892 |
| September 22, 2026 | 0.9643 |
| September 21, 2026 | 0.9643 |
| September 18, 2026 | 0.973 |
| September 17, 2026 | 0.973 |
| September 16, 2026 | 0.969 |
| September 15, 2026 | 1.014 |
| September 14, 2026 | 0.9852 |
| September 11, 2026 | 1.038 |
| September 10, 2026 | 1.022 |
| September 09, 2026 | 1.022 |
| September 08, 2026 | 1.026 |
| September 04, 2026 | 1.026 |
| Date | Value |
|---|---|
| September 03, 2026 | 1.014 |
| September 02, 2026 | 1.078 |
| September 01, 2026 | 0.9406 |
| August 31, 2026 | 1.010 |
| August 28, 2026 | 1.001 |
| August 27, 2026 | 1.046 |
| August 26, 2026 | 1.046 |
| August 25, 2026 | 1.054 |
| August 24, 2026 | 1.064 |
| August 21, 2026 | 1.127 |
| August 20, 2026 | 1.120 |
| August 19, 2026 | 1.208 |
| August 18, 2026 | 1.310 |
| August 17, 2026 | 1.054 |
| August 14, 2026 | 1.129 |
| August 13, 2026 | 1.135 |
| August 12, 2026 | 1.091 |
| August 11, 2026 | 1.074 |
| August 10, 2026 | 1.164 |
| August 07, 2026 | 1.192 |
| August 06, 2026 | 1.164 |
| August 05, 2026 | 1.156 |
| August 04, 2026 | 1.168 |
| August 03, 2026 | 1.160 |
| July 31, 2026 | 1.143 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| BioLineRx Ltd. | 0.703 |
| Kamada Ltd. | 1.729 |
| Can-Fite BioPharma Ltd. | 1.380 |
| Eocene Ltd. | 0.2783 |
| Revium Recovery, Inc. | -- |
Price to Book Value Related Metrics
| Price | 1.98 |
| Market Cap | 4.684M |